Evidence map›Paper›PMID 36605671›Full record

ReviewRSC advances2022

Recent development of analytical methods for disease-specific protein

Wenhua Hu, Guolin Zhang, Yu Zhou, Jun Xia, Peng Zhang, Wenjin Xiao, Man Xue, Zhaohui Lu, Shuang Yang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. O-GlcNAc informatics: advances and trends.Analytical and bioanalytical chemistry · 2025
    Review
  4. Article
  5. Tissue-specificeLife · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wenhua HuCenter for Clinical Mass Spectrometry, College of Pharmaceutical Sciences, Soochow University Suzhou Jiangsu 215123 China yangs2020@suda.edu.cn.
Guolin ZhangSuzhou Institute for Drug Control Suzhou Jiangsu 215104 China.
Yu ZhouLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou Zhejiang 310014 China.
Jun XiaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou Zhejiang 310014 China.
Peng ZhangDepartment of Orthopedics, The Second Affiliated Hospital of Soochow University Suzhou Jiangsu 215004 China.
Wenjin XiaoDepartment of Endocrinology, The Second Affiliated Hospital of Soochow University Suzhou Jiangsu 215004 China.
Man XueSuzhou Institute for Drug Control Suzhou Jiangsu 215104 China.
Zhaohui LuHealth Examination Center, The Second Affiliated Hospital of Soochow University Suzhou Jiangsu 215004 China luzhdoc@163.com.
Shuang YangCenter for Clinical Mass Spectrometry, College of Pharmaceutical Sciences, Soochow University Suzhou Jiangsu 215123 China yangs2020@suda.edu.cn.ORCID https://orcid.org/0000-0001-7958-0594
Soochow University · CNSuzhou Research Institute · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzymatic modification of protein serine or threonine residues by

Identifiers

PMID36605671
PMCPMC9768672
OpenAlexW4312071663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.